1. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond.
- Author
-
Lu, Jialin, Ma, Yuqing, Li, Qiuxin, Xu, Yihuan, Xue, Yiquan, and Xu, Sheng
- Subjects
CHIMERIC antigen receptors ,TUMOR treatment ,ANTIGEN presentation ,CANCER treatment ,CELLULAR therapy ,T cells - Abstract
With the advent of adoptive cellular therapy, chimeric antigen receptor (CAR)-T cell therapy has gained widespread application in cancer treatment and has demonstrated significant efficacy against certain hematologic malignancies. However, due to the limitations of CAR-T cell therapy in treating solid tumors, other immune cells are being modified with CAR to address this issue. Macrophages have emerged as a promising option, owing to their extensive immune functions, which include antigen presentation, powerful tumor phagocytosis, and particularly active trafficking to the tumor microenvironment. Leveraging their unique advantages, CAR-macrophages (CAR-M) are expected to enhance the effectiveness of solid tumor treatments as a novel form of immunotherapy, potentially overcoming major challenges associated with CAR-T/NK therapy. This review outlines the primary mechanism underlying CAR-M and recent progressions in CAR-M therapy, while also discussing their further applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF